Literature DB >> 15025854

Effect of lubricant type and concentration on the punch tip adherence of model ibuprofen formulations.

Matthew Roberts1, James L Ford, Graeme S MacLeod, John T Fell, George W Smith, Philip H Rowe, A Mark Dyas.   

Abstract

A model formulation, comprising ibuprofen and direct compression lactose (Tablettose 80) was used to assess the influence of two lubricants, magnesium stearate and stearic acid, on punch tip adherence. Lubricant concentrations were varied from 0.25% to 2% w/w. Formulations in the presence and absence of 0.5% w/w colloidal silica (Aerosil 200) were examined, to assess the influence of the glidant on the anti-adherent effects of the lubricants. Differential scanning calorimetry (DSC) was used to examine the effect of the lubricants on the melting temperature of ibuprofen. Tablets were compacted using a single punch tablet press at 10 kN using hard chrome-plated punches or at 40 kN using uncoated steel punches, tooling was 12.5-mm diameter in each case. The upper punch faces were characterized by obtaining Taylor Hobson Talysurf surface profiles. Following compaction, ibuprofen attached to the face was quantified by spectroscopy. At low concentrations of each lubricant, the levels of sticking observed were similar. Whilst sticking increased at magnesium stearate concentrations above 1%, sticking with stearic acid remained relatively constant at all concentrations. DSC revealed that the melting temperature of ibuprofen was lowered by the formation of eutectic mixtures with both lubricants. However, the onset temperature of melting and melting point were lowered to a greater extent with magnesium stearate compared with stearic acid. When using uncoated tooling at 40 kN, the deleterious effects of magnesium stearate on the tensile strength of the tablets also contributed to sticking. When using chrome-plated punches at 10 kN, the tensile strength reduction by the presence of magnesium stearate was less pronounced, as was the level of sticking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025854     DOI: 10.1211/0022357022827

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Difference in the lubrication efficiency of bovine and vegetable-derived magnesium stearate during tabletting.

Authors:  Abhay Gupta; Mazen L Hamad; Mobin Tawakkul; Vilayat A Sayeed; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2009-04-24       Impact factor: 3.246

2.  Critical Tools in Tableting Research: Using Compaction Simulator and Quality by Design (QbD) to Evaluate Lubricants' Effect in Direct Compressible Formulation.

Authors:  Nailla Jiwa; Yildiz Ozalp; Gizem Yegen; Buket Aksu
Journal:  AAPS PharmSciTech       Date:  2021-05-11       Impact factor: 3.246

3.  Mixing order of glidant and lubricant--influence on powder and tablet properties.

Authors:  Kalyana Pingali; Rafael Mendez; Daniel Lewis; Bozena Michniak-Kohn; Alberto Cuitino; Fernando Muzzio
Journal:  Int J Pharm       Date:  2011-02-26       Impact factor: 5.875

4.  Scanning Electron Microscope Observations of Powder Sticking on Punches during a Limited Number (N < 5) of Compactions of Acetylsalicylic Acid.

Authors:  Henrietta Tsosie; James Thomas; John Strong; Antonios Zavaliangos
Journal:  Pharm Res       Date:  2017-07-31       Impact factor: 4.200

5.  Molecular basis of crystal morphology-dependent adhesion behavior of mefenamic acid during tableting.

Authors:  Vrushali Waknis; Elza Chu; Roxana Schlam; Alexander Sidorenko; Sherif Badawy; Shawn Yin; Ajit S Narang
Journal:  Pharm Res       Date:  2013-08-14       Impact factor: 4.200

6.  A multivariate investigation into the relationship between pharmaceutical characteristics and patient preferences of bioequivalent ibuprofen tablets.

Authors:  Tatiana R Alonso; Adrianna Gagol; Maximilian Scherer; Antonio Matji; Santiago Torrado-Santiago; Dolores R Serrano; Alfredo Garcia-Arieta; Juan J Torrado
Journal:  Patient Prefer Adherence       Date:  2018-09-26       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.